These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 31811749

  • 41. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S, Huang X, Zhang K, Tan W, Lin Z, He Q, Chen Y, Shang C.
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [Abstract] [Full Text] [Related]

  • 42. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
    Bai Z, Li H, Li C, Sheng C, Zhao X.
    Medicine (Baltimore); 2020 Oct 02; 99(40):e21503. PubMed ID: 33019382
    [Abstract] [Full Text] [Related]

  • 43. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.
    Guo X, Lv X, Lv X, Ma Y, Chen L, Chen Y.
    Oncotarget; 2017 Jul 04; 8(27):44050-44058. PubMed ID: 28477010
    [Abstract] [Full Text] [Related]

  • 44. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J, Zhou C, Guo K, Li Q, Wang Z.
    J Cell Biochem; 2019 Jan 04; 120(1):213-223. PubMed ID: 30206981
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F, Xie C, Zhao W, Deng Z, Yang H, Fang Q.
    Clin Exp Med; 2017 Feb 04; 17(1):33-43. PubMed ID: 26433964
    [Abstract] [Full Text] [Related]

  • 47. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma.
    Konishi H, Ichikawa D, Yamamoto Y, Arita T, Shoda K, Hiramoto H, Hamada J, Itoh H, Fujita Y, Komatsu S, Shiozaki A, Ikoma H, Ochiai T, Otsuji E.
    Cancer Sci; 2016 Feb 04; 107(2):149-54. PubMed ID: 26614531
    [Abstract] [Full Text] [Related]

  • 48. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 49. Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrence.
    Wang SC, Li CY, Chang WT, Cheng WC, Yen CH, Tu WY, Lin ZY, Lin CC, Yeh ML, Huang CF, Huang JF, Dai CY, Chuang WL, Chen YL, Yu ML.
    Liver Int; 2021 May 01; 41(5):956-968. PubMed ID: 33346937
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y, Xu HF, Liu MY, Xu YJ, He JC, Zhou Y, Cang SD.
    World J Gastroenterol; 2019 Apr 21; 25(15):1890-1898. PubMed ID: 31057302
    [Abstract] [Full Text] [Related]

  • 52. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
    Toraih EA, Ellawindy A, Fala SY, Al Ageeli E, Gouda NS, Fawzy MS, Hosny S.
    Biomed Pharmacother; 2018 Jun 21; 102():653-669. PubMed ID: 29604585
    [Abstract] [Full Text] [Related]

  • 53. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X, Liu Y, Yu S.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul 21; 1863(7):1805-1816. PubMed ID: 28428004
    [Abstract] [Full Text] [Related]

  • 54. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
    Lin LY, Yang L, Zeng Q, Wang L, Chen ML, Zhao ZH, Ye GD, Luo QC, Lv PY, Guo QW, Li BA, Cai JC, Cai WY.
    Mol Cancer; 2018 Apr 24; 17(1):84. PubMed ID: 29690888
    [Abstract] [Full Text] [Related]

  • 55. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B, Lou W, Xu L, Fan W.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30224380
    [Abstract] [Full Text] [Related]

  • 56. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J.
    Cancer Lett; 2014 Mar 01; 344(1):20-27. PubMed ID: 24183851
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.